Clover Health Investments Corporation (CLOV) Options

$CLOV – New Charles Schwab fund invested $1 million USD in Clover Health. FNDA - Schwab Fundamental U.S. Small Company Index ETF filed a NPORT-P form on July 24, 2024. They owned 958,430 shares of Clover Health Investments Corp valued at $1,054,273 USD as of May 31, 2024.

how many shares will the company dump????

$CLOV __ 18% INCREASE in Clover Health shares Last Quarter. Jupiter Asset Management Ltd filed a 13F-HR form on May 10, 2024. They owned 4,525,079 shares of Clover Health valued at $3,592,913 USD as of March 31, 2024. They had 3,832,201 shares on Dec 31, 2023.

A deep look at CLOV! Lots of great information. Looking really good!
https://www.youtube.com/live/oJs28Ir_vuk
$CLOV

Clovers' new spinoff company Counterpart Health and Counterpart assistant is now available to every doctor, hospital, medical provider in the world for a fee. They recently patented this after 4 years in the development stage. Within the last 3 weeks Clover has already signed up tens of thousands of medical providers nationwide. This system is a doctor's doctor of sorts that does most of the work for your doctor. It comes up with instant solutions/diagnoses that your doctor wouldn't have considered or thought of. Super smart and super profitable for Clover. We now have our hands and the potential to be in every doctor's office/hospital/healthcare provider in the world. As said before, within the last 3 weeks they have signed up tens of thousands of medical providers. More to be released the Q2 earnings report on August 2. Could be sooner.

https://investors.cloverhealth.com/news-releases/news-release-details/clover-health-announces-counterpart-health-new-saas-and-tech

60 Patents and Climbing
I periodically check this site for new patents. Since Clover's white paper on medication detection/adherence there have been 2 new patents listed.

Looks like they are doing everything they can to protect their software Clover Assistant.

Latest Patent release was on 5/14/2024 with another one right behind it on 4/30/2024

Toy mentioned more white papers so this is where I would expect to see something before a PR announcement.

These patents speak to something really bad ass and useful. This is huge for healthcare in general. CA Clover Assistant) truly is something great.
$CLOV

85% MCR (Medical Cost Ratio) is good. Clover is achieving 80% MCR due to Clover Assistant. A lot of cash can be saved when others adopt Counterpart Assistant SAAS (Software as a service). On $5B in revenue, CA (Chartered accounts) can save $250 M. The MA (Medicare Advantage) market size is over $430 Billion. Achieving 80% MCR vs 85% MCR saves $21.5 Billion. If Clover can capture 10% of this savings we are looking at 2.15 billion revenues, and a PE of 10 puts clover at 21.5 Billion market cap or $40 / share.
$CLOV

CEO Andrew Toy posted this on Linkedin last night
The question of when a surgeon should retire has been debated for decades.

Aging brings physical and cognitive changes that can impact a surgeon's performance. Yet, no federally mandated retirement age exists for surgeons in the U.S, leaving this an unfortunate gray area filled with complex considerations.

Aging can lead to a decline in vision, dexterity, and cognitive skills, which are critical for performing surgery. Anecdotes and studies suggest that older surgeons may struggle with new technologies or more complex procedures. For example, some older surgeons continue performing outdated techniques due to their remoteness from recent education and advancements. This can lead to increased risks during surgery, as seen in cases where hospitals have had to silently compensate for an aging surgeon's declining skills until a serious incident occurs.

Additionally, if you read the linked paper, there have been instances where those close to the surgeon feel the need to protect them by shielding their performance or even boosting it. For example, extra staff may be allocated, or special preparations made, to mitigate the risks posed by an aging superstar surgeon’s declining abilities. This form of "protection" can inadvertently mask the underlying issue and delay necessary interventions.

However, experience and wisdom gained over years also can’t be discounted. Many older surgeons offer unparalleled expertise and judgment honed over decades, especially when treating rarer conditions. The challenge is balancing the value of this experience with the potential risks posed by physical and cognitive decline.

Mandatory retirement, as seen in other professions like aviation, is one approach but presents a risk of running afoul of age discrimination laws. Instead, some suggest implementing regular, comprehensive evaluations to ensure surgeons maintain the necessary skills. Yet, the medical community has not reached a consensus on how to effectively assess and address this issue.

The key is fostering a culture where surgeons plan for retirement and transition to roles where their experience remains valuable, such as teaching or mentoring. By doing so, we can respect the contributions of aging surgeons while ensuring patient safety remains paramount.

At the end of the day it comes down to patient risk tolerance and confidence. Everyone wants to know they’re in good hands.

https://lnkd.in/gmwnwqbU

hashtag#Healthcare hashtag#HealthyAging hashtag#PatientSafety hashtag#MedicalEthics hashtag#physician hashtag#retirement
Activate to view larger image,
Image preview

What exactly did they do the last time they were in~? Nothing~!
Don't count on anything. Republicans want to take Medicare and SSI away (privatizing SSI so we invest it with their billionaire buddies in the stock market..... in this corrupt market~?).
Are you kidding me dude~?

BTW, January 6th was an attempted coup. People defecated in the Capital building and they are called PATRIOTS while
guys that stormed the beaches in Normandy were called stupid and suckers by that Elmer Gantry wanna be. He was out golfing and didn't even have the decency to call the family of the guy who took the bullet meant for him. He was busy golfing. Are you kidding me~? Joe called her though. Where was Donny boy~? He used that guy's death for his benefit and he went out golfing. What a creepy dude.

WOW~! So what did the Republicans do the last time~? I'm waiting...............while my cousin died of a rare liver cancer
because that administration let insurance companies jack their rates to the max on Obama care~? He did NOTHING~! Like he always does.

Scam artist........... ask Avalon Tile and Carpet how much HE ripped them off when he left his Atlantic City casinos. $$ Millions. Convicted felon 34 counts.

Healthcare investors are expecting the Republican presidential candidate to ease regulations on Medicare Advantage if the former president wins and returns to the White House. Regulatory easing on Medicare Advantage could also rekindle talks on possible mergers between health insurers.
Under the current administration, the Centers for Medicare & Medicaid Services has hardened its stance on the program after it faced criticism for insurers overbilling the government and denying care to seniors too many times, the Wall Street Journal reported.
Republicans tend to favor privatizing government services and have been friendlier to Medicare Advantage plans, a trend that investors are betting could continue under a second Trump administration.

Also Read: UnitedHealth Analysts Boost Their Forecasts Following Upbeat Earnings

Regulatory easing on Medicare Advantage could also rekindle talks on possible mergers between health care providers.
$CLOV

Worth repeating! Adding some CLOV everyday at this level!

85% MCR is good. Clover is achieving 80% MCR due to Clover Assistant. A lot of cash can be saved when others adopt Counterpart Assistant SAAS. On 5 B in revenue, CA can save $250 M. The MA market size is over $430 Billion. Achieving 80% MCR vs 85% MCR saves $21.5 Billion. If Clover can capture 10% of this savings we are looking at 2.15 billion revenues, and a PE of 10 puts clover at 21.5 Billion market cap or $40 / share.

This will take some time but on the way to $40 a share will be tons of fun in itself! GLTA LONGS!

$CLOV

My target price is much higher than $10. Once this Company gets it in gear, it will be hard to stop.
My one account is an average price of $21, the other is an average price of $8 and change.
I'm looking for $CLOV to squeeze once the Company's fundamentals become sound and the balance sheet
starts looking better. IMO $CLOV is turning the corner. "They" know it too.

GLTA

Ya all good making large

thanks will go for

I'm in CLOV for the long term. My price target is $10.00

should we se 2$ in 2 weeks ??

Your target price was hit a couple of days ago. https://investorshub.advfn.com/boards/read_msg.aspx?message_id=174701605

85% MCR is good. Clover is achieving 80% MCR due to Clover Assistant. A lot of cash can be saved when others adopt Counterpart Assistant SAAS. On 5 B in revenue, CA can save $250 M. The MA market size is over $430 Billion. Achieving 80% MCR vs 85% MCR saves $21.5 Billion. If Clover can capture 10% of this savings, we are looking at 2.15 billion revenues, and a PE of 10 puts clover at 21.5 Billion market cap or $40 / share.
$CLOV

From a friend over on the Yahoo message board.

Well first let me say, I was glad to hear Director Anna Loengard bought another 25,671 shares just a short while ago, adding to the load of shares she already owns. She paid between 93 and 96 cents. I realize many on this board are down a lot and have waited way too long for a turnaround, some of which believe to be impossible. I believe there is in fact a turnaround starting already. The last 3 reports made some progress to that end. The fact that they intend to buy back 20 million in shares, will no doubt be helpful as well as insiders buying shares in the open market with their own cash. I did very well with Oscor Health, (OSCR) and buying at 2 and change many said the same things there, now 23 per share in less than 2 years. I don't know what the future is for Clover, but I know it's making progress, and if it turns the corner in a quarter or two, many longs here like me will make a very nice profit. Good luck Longs.....

$CLOV

That does not compute Will Robinson. :)

CLOV is an short play hm not for me - not in long time her

in 1.71 CLOV

yes but go PLUG/AMC and GME too CLOV

More shared analyst comments on CLOV.
$CLOV Clover Health will sign multiple multimillion SAAS deals, and every analysis that has ever been written previously will no longer matter. Profitable and expanding MA business in 2025 + additional multimillion revenue business with minimal cap ex = buy through the $10’s

CLOV's short interests have fallen to about 35.32 million shares (8.81% of float) as reported by Benzinga. Despite a reduction of short interests, CLOV still has more short interests than most of its peers according to Benzinga Pro.

That is the short interest they allow you to see. None of these platforms including ORTEX has accurate data. It's all flawed.
Plug into that the naked shorts that still have obligations to cover in $CLOV. JMO that these naked shorts are still heavily into this play.

I know what I should do but am reluctant to do it. Comes with getting hosed in this market for too long.
Will take a few days for money to clear too. Should I~? Oh, the choices we must make. Stand pat or add~?

Wish I had several runners. It would make life so much easier.

$CLOV baby~!

12 July, 2024 Analyst opinion.
Interestingly, the stock closed just enough to force those retail groups handing over the shares this weekend. If CLOV gaps up on Monday, the same retail groups would chase after the shares lost at a much higher price(s), in my opinion.

CLOV will continue on its path to cross over the 52-week high, hopefully sooner than next weekend, and going further on the journey to challenge the $3.55 line...

CLOV's short interests have fallen to about 35.32 million shares (8.81% of float) as reported by Benzinga. Despite a reduction of short interests, CLOV still has more short interests than most of its peers according to Benzinga Pro. It is an indication that the street is gaining a confidence of a turn-around of CLOVER the company and the stock with recent short interest drop-off.

Now that CLOV has crossed the 52-week high this morning, CLOV is continuing its journey to cross the $3.55 line. Based on the trading actions this morning, I believe apparent overwhelming imbalance of sellers and buyers would drive this run to $3.55 relative smoothly and quickly....

lol hehe

Shorty has 5 gallon buckets of red paint out to throw on this stock. Sad but true. Without that illegal activity we would be well over $2. Fight and recommend to friends. I have several friends are really liking what they see here.

$CLOV

The big boys are due back! This stock is about to go into full on BREAKOUT MODE!

Clover Health Investments, Corp. (US:CLOV) has 167 institutional owners and shareholders that have filed 13D/G or 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 89,822,555 shares. Largest shareholders include Vanguard Group Inc, Renaissance Technologies Llc, BlackRock Inc., VTSMX - Vanguard Total Stock Market Index Fund Investor Shares, VEXMX - Vanguard Extended Market Index Fund Investor Shares, Pnc Financial Services Group, Inc., Jupiter Asset Management Ltd, NAESX - Vanguard Small-Cap Index Fund Investor Shares, Geode Capital Management, Llc, and D. E. Shaw & Co., Inc. .

Clover Health Investments, Corp. (NasdaqGS:CLOV) institutional ownership structure shows current positions in the company by institutions and funds, as well as latest changes in position size. Major shareholders can include individual investors, mutual funds, hedge funds, or institutions. The Schedule 13D indicates that the investor holds (or held) more than 5% of the company and intends (or intended) to actively pursue a change in business strategy. Schedule 13G indicates a passive investment of over 5%.

They sure are throwing everything they can at us. A big burn is inevitable. Couldn't happen to a better group of darkness with bad intentions.

$CLOV

shorts must cover

The accumulation here over the past several weeks has been outstanding!

we need some news friday or monday

Here I am lol.

Old 52-week high smashed! Love your post!🥰

LMFAO @ butt PLUG comment! And that is exactly where it belongs!

From another board, this may also pertain to what is happening at $CLOV.

DR_rugby

Tuesday, July 16, 2024 10:06:38 AM

Post#
141513
of 141517
So this is interesting

Price is creeping up
Across the board walk

When they removed the FDIC chair
Who was blocking the banking reserve limits
To higher banking reserve values and issues that scathing report on derivatives

Did that banking risk transfer cause the beginning of unwinding of swaps ?? Or the payment of swaps?? Which is causing shorts to begin to cover ?? On a small scale then soon after the wheel gets really going good

Then PPS across the board will pop

Thus a crack up boom

Killing the FED and banking system??

Forcing a new shares system with blockchain tech with CAT system tracking ??

Hum

Makes ya think

GLTA

52 week high today. IMO she is ready to blow. Shorts are having a hard time holding CLOV down. The next news event whether it's another Form 4 insider buy or August reporting Q2 earnings and 2024-2025 outlook watch out! Anything that creates a big volume day were going to see $2! Just my opinion! Back up the truck. I did at .85 and just keep adding!

$CLOV

All good bro , my brother and I made a total of 63k yesterday , kicking ass , butt PLUG is the new deal sublover CLOV will take its time

on shrooms with a butt PLUG in my keister Going 4 boners CLOV

Pura Vida
Will enjoy 2 more weeks

Fuclin A EXACTLY! $CLOV is an investment and not a P&D like so many others on NASDAQ :)

Nice and steady since 1$.

Top of the morning Jimmy Joe! GO $CLOV

Look at the chart. Inverted head and shoulders coming.
M pattern, and M stands for Money~!

Hoping $CLOV comes back down to $1.40...... then WHAM~! Back up baby~!

$CLOV

I am adding everyday as she continues to show that a major move up is imminent. Big things coming to CLOV IMO. I have many friends who are doing the same. It's only a matter of time. Earnings are coming and insiders continue to add themselves. Shorty is present or CLOV would be MUCH higher. Just look at all of the 1 to 40 share executed sell orders. There are 2 or 3 after every decent buy order just to being it right back down. Bigger volume is in our future which will fix this problem!
$CLOV

excellent we sure know how to pick'em , PLUG 293 / CLOV

sweet nice day , loaded up on PLUG up 2k so far CLOV

Not much real selling here today. With this above average volume the SHORTS are getting a good workout trying to hold CLOV down! Couldn't happen to a better group of non-investors. Big burn coming to them in their non-futures and their naked shares.

CLOV$